Curt Mikael von Euler-Chelpin

Directeur/Membre du Conseil chez DICOT PHARMA AB

Profil

Curt Mikael von Euler-Chelpin is currently the Chief Executive Officer at KDev Oncology AB.
He is also the Chief Executive Officer & Director at M Von Euler Consulting AB, an Independent Director at Dicot AB, a Director at Annexin Pharmaceuticals AB, a Director at Bostadsrättsföreningen Mälarvik, a Faculty Member at The Royal College of Physicians, and the Chief Medical Officer & VP-Clinical Development at Akinion Pharmaceuticals AB.
Previously, Dr. von Euler-Chelpin served as the Chief Executive Officer at Axelar AB.
He was also the Director of Clinical Strategy at AstraZeneca PLC and AstraZeneca AB.
Additionally, he worked as a Principal at Hoffmann-La Roche, Inc. and Vice President-Oncology MDC at GlaxoSmithKline, Inc. He held the position of Senior Vice President at Aprea Therapeutics AB and Vice President-Oncology at GlaxoSmithKline AB.
He was the Head-Cluster at Roche AB and the Chief Medical Officer & Head-Research at Targovax Oy.
Dr. von Euler-Chelpin obtained a doctorate degree from Karolinska Institutet.

Postes actifs de Curt Mikael von Euler-Chelpin

Sociétés	Poste	Début
DICOT PHARMA AB	Directeur/Membre du Conseil	16/04/2018
ANNEXIN PHARMACEUTICALS AB	Directeur/Membre du Conseil	-
KDev Oncology AB	Directeur Général	-
Akinion Pharmaceuticals AB	Directeur Technique/Scientifique/R&D	-
The Royal College of Physicians	Corporate Officer/Principal	-
M Von Euler Consulting AB	Directeur Général	15/12/2014
Bostadsrättsföreningen Mälarvik	Directeur/Membre du Conseil	18/12/2015

Anciens postes connus de Curt Mikael von Euler-Chelpin

Sociétés	Poste	Fin
Aprea Therapeutics AB	Corporate Officer/Principal	01/09/2017
Targovax Oy	Directeur Technique/Scientifique/R&D	01/09/2012
░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░

Formation de Curt Mikael von Euler-Chelpin

Karolinska Institutet

Doctorate Degree